Search clinical trials for: AMT

Total 3784 results

VA Office of Research and Development

Completed

Telehealth Therapy for Chronic Pain: Comparison of In-person vs. Video-administered ACT for Pain (TTCP)

Chronic Pain

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Venetoclax and Acalabrutinib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

Recurrent Mantle Cell Lymphoma | CD20 Positive | Refractory Mantle Cell Lymphoma | Blastoid Variant Mantle Cell Lymphoma | CCND1 Protein Overexpression | CD5 Positive | FCER2 Negative | Pleomorphic Variant Mantle Cell Lymphoma | t(11;14)(q13;q32)

United States
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Immediate Versus Deferred Start of Anti-HIV Therapy in HIV-Infected Adults Being Treated for Tuberculosis (STRIDE)

HIV Infection | Tuberculosis

United States, Peru, Kenya, Malawi, Uganda, Brazil, South Africa, Zimbabwe, India, Thailand, Botswana, Haiti, Zambia
Region Skane

Withdrawn

Acceptance and Commitment Based Group Therapy for Cancer Patients

Cancer | Psychological Distress

Sweden
Aspire Health Science

Unknown

ACT-20 in Patients With Severe COVID-19 Pneumonia

COVID-19 Pneumonia
AbbVie

Completed

A Phase 2a Study Evaluating the Safety and Efficacy of ABT-981 in Patients With Erosive Hand Osteoarthritis

Erosive Hand Osteoarthritis
Abbott

Completed

A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ABT-384 in Elderly Subjects

Healthy

United States
ALK-Abelló A/S
Ergomed; ACM Pivotal Global Central Laboratory

Completed

House Dust Mite Treatment of Asthma. The MITRA Trial House Dust Mite Treatment of Asthma (MITRA)

Asthma

Germany
AbbVie

Completed

A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Subjects With Genotype 1 Infection

Chronic Hepatitis C | Hepatitis C Virus | HCV
Idorsia Pharmaceuticals Ltd.

Completed

Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT-389949 in Healthy Subjects

Healthy Subjects

United Kingdom
Children's Hospital of Philadelphia
National Institute of Mental Health (NIMH); Rutgers University

Completed

Comparison of Three Therapy-Based Interventions for Preventing Depression in Adolescents

Depression

United States
John Sampson

Completed

Evaluation of Recovery From Drug-Induced Lymphopenia Using Cytomegalovirus-specific T-cell Adoptive Transfer (ERaDICATe)

Glioblastoma

United States
Tel Aviv University

Completed

Attention Bias Modification Treatment (ABMT) for Anxiety Disorders in Youth

Anxiety Disorders

Israel
Region Skane
Lund University

Recruiting

A Comparison of Two Ultra-brief Interventions in Primary Care for Patients With Anxiety, Depression, and Stress. (RNTACTSweden)

Anxiety | Mental Disorder | Mental Stress | Mental Depression | Mental Health Issue | Rumination - Thoughts

Sweden
Universidad Nacional de Educación a Distancia
Ministerio de Economía y Competitividad, Spain

Completed

Internet Transdiagnostic-CBT for Anxiety and Depression in Adolescents

Depressive Disorder | Emotional Disorder | Anxiety Disorder

Spain
Idorsia Pharmaceuticals Ltd.

Completed

Clinical Study to Assess the Pharmacokinetics, Safety, and Tolerability of ACT-129968 in Healthy Subjects

Healthy Subjects

Germany
University of North Carolina, Chapel Hill

Recruiting

Animal Assisted Therapy in Pediatric Dentistry (AAT)

Anxiety

United States
Valerie Taylor
University Health Network, Toronto

Active, not recruiting

Safety and Efficacy of Fecal Microbiota Transplantation in a Population With Bipolar Disorder

Bipolar Depression

Canada
AbbVie (prior sponsor, Abbott)

Completed

An Evaluation of the Biodistribution and Imaging Characteristics of ABT-806i (111In-ABT-806) in Subjects With Advanced Solid Tumor Types

Advanced Solid Tumors

Australia
Celltrion

Active, not recruiting

Study to Evaluate and Compare the Efficacy and Safety of AZM and AML Combined and Alone in Mild-to-moderate Essential Hypertensive Subjects

Essential Hypertension

Korea, Republic of
Idorsia Pharmaceuticals Ltd.

Completed

A Study to Examine the Safety, Tolerability, and Pharmacokinetics of Single- and Multiple-ascending Doses of ACT-1014-6470 in Healthy Subjects

Healthy

Netherlands
University of Zurich

Recruiting

The Effects of Perioperative Painting Art Therapy (LOM® Solution Centered Art Therapy) in Surgical Patients

Posttraumatic Stress Disorder | Pancreas Cancer | Depression, Anxiety | Lower Gastrointestinal Neoplasms Benign

Switzerland
Amasya University

Recruiting

Art Therapy and Caregivers Stress

Caregiver Stress Syndrome

Turkey
University of South Florida

Not yet recruiting

Novel Adaptive Cognitive Training in Autistic Adults With Co-occurring Insomnia

Insomnia | Autism Spectrum Disorder
Ascentawits Pharmaceuticals, Ltd

Recruiting

A Phase I/II Study of AST-001 in Subjects With Advanced Solid Tumors

Pancreatic Cancer | Solid Tumor

China
Mersin University

Not yet recruiting

Effect Of Art Therapy Applied to Individuals With Substance Use Subject to Supervised Release

Substance Use

Turkey
Peking University First Hospital
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical... and other collaborators

Recruiting

A Phase II Neoadjuvant Study of Darolutamide Plus ADT in Men With Localized Prostate Cancer

Prostate Cancer

China
Amgen

Recruiting

Study to Explore the Safety, Tolerability, and Pharmacokinetics of AMG 305 in Subjects With Advanced Solid Tumors

Advanced Solid Tumors

United States, Korea, Republic of, Spain, Australia, Germany, France, Japan, Canada
Taiwan Bio Therapeutics Co., Ltd.

Recruiting

Intracoronary Administration of OmniMSC-AMI for Acute ST-segment Elevation Myocardial Infarction Patients

Safety Issues

Taiwan
University Hospital, Grenoble
Université Grenoble-Alpes

Recruiting

Improving Emotion Regulation Flexibility: Testing the Efficacy of an Emotion Regulation Program in College Students (REFLEX)

Anxiety Depression | Emotion Regulation

France
SleepUp Tecnologia em Saúde Ltda

Recruiting

Actigraphy, Wearable EEG Band and Smartphone for Sleep Staging

Insomnia | Sleep

Brazil
Centre Hospitalier de Perigueux
University Hospital, Limoges

Recruiting

" Application of Art Therapy in Oncology: Evaluation of the Symptomatic of Patients Suffering From a Cancerous Disease" (ARONCO)

Therapy-Associated Cancer

France
Amgen

Available

AMG 714 Expanded Access Program

Celiac Disease
Johns Hopkins University

Completed

AMP Step Wedge Trial (AMP SWT)

Disability | Immobility

United States
Amgen

Terminated

Study of AMG 910 in Subjects With CLDN18.2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma

Gastric and Gastroesophageal Junction Adenocarcinoma

Korea, Republic of, Taiwan, Spain, Austria, United States, France, Japan, Germany, Netherlands
Amgen

Terminated

Assessment of AMG 420 in Subjects With Relapsed and/or Refractory Multiple Myeloma (AMG420)

Relapsed and/or Refractory Multiple Myeloma

United States, Japan, Belgium, Australia, Switzerland
Swing Therapeutics, Inc.

Active, not recruiting

"REACT-FM" Real-World Evidence From Smartphone-Based Acceptance and Commitment Therapy in Fibromyalgia (REACT-FM)

Fibromyalgia

United States
University of Oxford
Oxford University Hospitals NHS Trust; Oxford Health NHS Foundation Trust

Completed

Fluid Restriction and Quality of Life on Dialysis

End Stage Renal Disease

United Kingdom
Amgen

Terminated

Safety Study of AMG 228 to Treat Solid Tumors

Melanoma | Cancer | Colorectal Cancer | Advanced Solid Tumors | Squamous Cell Carcinoma of the Head and Neck | Non-small Cell Lung Cancer | Oncology | Tumors | Advanced Malignancy | Oncology Patients | Transitional Cell Carinoma of Bladder

Belgium, France, United States, Germany, Australia
Daewoong Pharmaceutical Co. LTD.

Completed

Study to Evaluate the Long Term Safety and Efficacy of DWP16001 Compared to Placebo in the Treatment of T2DM.

T2DM (Type 2 Diabetes Mellitus)

Korea, Republic of
Universidad Europea de Madrid

Completed

Effectiveness of a Program Based on Observation-action Training (AOT) in Patients With Cognitive Impairment.

Cognitive Impairments

Spain
Amgen

Withdrawn

A Study of Subcutaneous (SC) AMG 701 in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) (ProxiMMity-1)

Relapsed/Refractory Multiple Myeloma
Kartos Therapeutics, Inc.

Completed

A Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple Myeloma

Cancer | Glioblastoma | Multiple Myeloma | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology Patients

United States, France, Netherlands
AbbVie (prior sponsor, Abbott)

Terminated

This is a Safety and Tolerability Study Evaluating a New Treatment for Subjects With Mild to Moderate Alzheimer's Disease

Alzheimer's Disease

United States, Poland, Russian Federation, South Africa, Ukraine, United Kingdom
Cytokinetics

Completed

Pharmacokinetics Study of AMG 423 in Healthy Subjects and Subjects With Various Degrees of Renal Insufficiency

Heart Failure

United States
Lineage Cell Therapeutics, Inc.

Completed

Dose Escalation Study of AST-OPC1 in Spinal Cord Injury

Cervical Spinal Cord Injury | Spine Injury | Spinal Cord Trauma

United States
AstraZeneca

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Moderate to Severe Psoriasis

Psoriasis

Australia, New Zealand
Idorsia Pharmaceuticals Ltd.

Completed

Study of the Way the Body Takes up, Distributes, and Gets Rid of ACT-541468 in Subjects With Abnormal Kidney Function Compared to Healthy Subjects

Healthy | Renal Insufficiency

Germany
Karolinska Institutet

Completed

Internet-based Acceptance and Commitment Training for Elite Ice Hockey Players

Mental Health | Performance Anxiety | Performance Enhancement

Sweden
Fondazione Don Carlo Gnocchi Onlus

Unknown

Action Observation Treatment in Parkinson's Patients (AOT-PA)

Parkinson

Italy

Search clinical trials for: AMT

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Austria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations